Skip to main content

A systematic review of the factors associated with the initiation of biologicals in patients with rheumatological conditions.

Publication ,  Conference
Png, WY; Kwan, YH; Lim, KK; Chew, EH; Lui, NL; Tan, CS; Østbye, T; Thumboo, J; Fong, W
Published in: Eur J Hosp Pharm
May 2019

OBJECTIVES: Biologicals play a crucial role in managing some of the rheumatological diseases, thus it is important for clinicians, healthcare institutions and policy-makers to understand why biologicals are initiated or refused so as to make better decisions to improve patients' disease outcomes. Although there have been many studies investigating factors associated with the initiation of biologicals for patients with rheumatological conditions, there have been no systematic reviews that provide a comprehensive summary. We aim to provide a summary of factors associated with biologicals' initiation for patients with rheumatological conditions. METHODS: We performed a literature search in PubMed, Embase and PsycINFO. We identified and screened studies according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Factors were presented according to patient, disease-related, therapy-related, healthcare team-related and system in-place factors. RESULTS: A total 1755 articles were reviewed and 24 articles were found to be relevant to our objective. Forty four factors reviewed were placed into five main categories: patient factors (n=13); disease-related factors (n=11); therapy-related factors (n=7); healthcare team-related factors (n=4) and system in-place-related factors (n=9). The factors studied by the published papers found to be associated with decisions to initiate biologicals varied widely. CONCLUSION: Forty two factors of five different categories were found to be associated with biologicals' initiation for patients with rheumatological conditions. Clinicians need to be mindful of the complex nature of these factors to optimise therapy of patients with rheumatological conditions. Healthcare institutions and policy- makers ought to be aware of any potential barriers to successful biologicals' treatment and address them accordingly.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Eur J Hosp Pharm

DOI

ISSN

2047-9956

Publication Date

May 2019

Volume

26

Issue

3

Start / End Page

163 / 169

Location

England

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Png, W. Y., Kwan, Y. H., Lim, K. K., Chew, E. H., Lui, N. L., Tan, C. S., … Fong, W. (2019). A systematic review of the factors associated with the initiation of biologicals in patients with rheumatological conditions. In Eur J Hosp Pharm (Vol. 26, pp. 163–169). England. https://doi.org/10.1136/ejhpharm-2017-001431
Png, Wan Yu, Yu Heng Kwan, Ka Keat Lim, Eng Hui Chew, Nai Lee Lui, Chuen Seng Tan, Truls Østbye, Julian Thumboo, and Warren Fong. “A systematic review of the factors associated with the initiation of biologicals in patients with rheumatological conditions.” In Eur J Hosp Pharm, 26:163–69, 2019. https://doi.org/10.1136/ejhpharm-2017-001431.
Png WY, Kwan YH, Lim KK, Chew EH, Lui NL, Tan CS, et al. A systematic review of the factors associated with the initiation of biologicals in patients with rheumatological conditions. In: Eur J Hosp Pharm. 2019. p. 163–9.
Png, Wan Yu, et al. “A systematic review of the factors associated with the initiation of biologicals in patients with rheumatological conditions.Eur J Hosp Pharm, vol. 26, no. 3, 2019, pp. 163–69. Pubmed, doi:10.1136/ejhpharm-2017-001431.
Png WY, Kwan YH, Lim KK, Chew EH, Lui NL, Tan CS, Østbye T, Thumboo J, Fong W. A systematic review of the factors associated with the initiation of biologicals in patients with rheumatological conditions. Eur J Hosp Pharm. 2019. p. 163–169.

Published In

Eur J Hosp Pharm

DOI

ISSN

2047-9956

Publication Date

May 2019

Volume

26

Issue

3

Start / End Page

163 / 169

Location

England

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences